3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
9
Lung Neoplasms
4
Colorectal Neoplasms
3
Neoplasm Metastasis
2
Carcinoma, Renal Cell
2
Solid Tumors
1
Rectal Neoplasms
1
Neoplasms
1
Kidney Neoplasms
1
Colonic Neoplasms
1
Brain Neoplasms
1
Advanced Solid Tumor
1
Interventions
cabozantinib
5
Nivolumab
4
Ipilimumab
4
Axitinib
4
pembrolizumab
3
Blood Specimen Collection
3
zimberelimab
2
atezolizumab
2
Surveys and Questionnaires
2
Sunitinib
2
Irinotecan
2
temsirolimus
1
spartalizumab
1
salicylhydroxamic acid
1
palbociclib
1
orellanine
1
olaparib
1
liposomal doxorubicin
1
lenvatinib
1
gallium Ga 68 dotatate
1
fludarabine
1
brodalumab
1
belzutifan
1
aldesleukin
1
adagrasib
1
Vincristine
1
Temozolomide
1
Taxes
1
Selenomethionine
1
Ropivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
adagrasib
×
90 days
×
Clear all
NCT06026410
2026-04-14
FIT-001
Kura Oncology, Inc.
Phase 1
Recruiting
300 enrolled